IRIS
DE VITO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.341
AS - Asia 3.316
SA - Sud America 1.869
EU - Europa 1.499
Continente sconosciuto - Info sul continente non disponibili 194
AF - Africa 137
OC - Oceania 6
AN - Antartide 1
Totale 18.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.134
BR - Brasile 1.663
SG - Singapore 1.465
CN - Cina 562
IT - Italia 469
HK - Hong Kong 425
VN - Vietnam 344
DE - Germania 271
FR - Francia 150
FI - Finlandia 140
GB - Regno Unito 108
CA - Canada 91
AR - Argentina 78
IN - India 73
BD - Bangladesh 66
MX - Messico 62
TR - Turchia 52
UA - Ucraina 50
RU - Federazione Russa 48
NL - Olanda 42
IQ - Iraq 37
EC - Ecuador 36
ZA - Sudafrica 36
PK - Pakistan 34
ES - Italia 30
JP - Giappone 29
VE - Venezuela 29
PL - Polonia 27
CO - Colombia 25
ID - Indonesia 25
CZ - Repubblica Ceca 24
MA - Marocco 24
UZ - Uzbekistan 23
SE - Svezia 22
AT - Austria 19
KR - Corea 19
AE - Emirati Arabi Uniti 18
JM - Giamaica 15
LT - Lituania 15
IL - Israele 14
NP - Nepal 14
BE - Belgio 13
KE - Kenya 12
TN - Tunisia 12
AZ - Azerbaigian 11
KG - Kirghizistan 11
PS - Palestinian Territory 11
SA - Arabia Saudita 11
UY - Uruguay 11
JO - Giordania 10
MY - Malesia 10
RS - Serbia 10
DO - Repubblica Dominicana 9
RO - Romania 9
UG - Uganda 9
CL - Cile 8
IE - Irlanda 8
LB - Libano 8
PE - Perù 8
PH - Filippine 8
BG - Bulgaria 7
PY - Paraguay 7
SN - Senegal 7
AU - Australia 6
DZ - Algeria 6
EG - Egitto 6
AL - Albania 5
CR - Costa Rica 5
GE - Georgia 5
HN - Honduras 5
HU - Ungheria 5
KZ - Kazakistan 5
OM - Oman 5
TH - Thailandia 5
AM - Armenia 4
CI - Costa d'Avorio 4
NI - Nicaragua 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
GR - Grecia 3
MK - Macedonia 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
BW - Botswana 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
GD - Grenada 2
HR - Croazia 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MT - Malta 2
MZ - Mozambico 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
Totale 18.145
Salva come PNG Salva come JPEG
Città #
Dallas 7.703
Singapore 777
San Jose 535
Hong Kong 422
Ashburn 371
Chandler 345
New York 234
Beijing 214
Council Bluffs 194
Munich 165
Columbus 164
São Paulo 129
Los Angeles 113
Lauterbourg 110
Ho Chi Minh City 104
Helsinki 101
Hanoi 79
Santa Clara 74
Princeton 68
Sassari 63
Rio de Janeiro 60
Shanghai 56
Belo Horizonte 51
Rome 38
Brasília 37
Montreal 36
Orem 35
Atlanta 34
Cagliari 34
Boardman 31
Curitiba 30
Denver 30
Frankfurt am Main 27
Tokyo 27
Brno 24
Chicago 24
London 24
Warsaw 24
Amsterdam 23
Chennai 22
Phoenix 22
San Francisco 22
Brooklyn 21
Buffalo 21
Campinas 21
Toronto 21
Johannesburg 20
The Dalles 20
Fortaleza 19
Salvador 19
Nuremberg 18
Tashkent 18
Guayaquil 17
Haiphong 17
Palermo 17
Poplar 17
Seoul 17
Turku 17
Boston 16
Dhaka 16
Guarulhos 16
Porto Alegre 16
Recife 16
Wilmington 16
Lappeenranta 15
Mexico City 15
Sorocaba 15
Stockholm 15
Ankara 14
Da Nang 14
Falkenstein 14
Milan 14
Baghdad 13
Goiânia 13
Houston 13
Lahore 13
Mumbai 13
Ribeirão Preto 13
Düsseldorf 12
São José dos Campos 12
Bishkek 11
Brussels 11
Contagem 11
Florianópolis 11
Istanbul 11
Manchester 11
Nairobi 11
Santo André 11
Xi'an 11
Alghero 10
Amman 10
Baku 10
Florence 10
Jacksonville 10
Ottawa 10
Romola 10
Turin 10
Buenos Aires 9
Kampala 9
Kingston 9
Totale 13.496
Salva come PNG Salva come JPEG
Nome #
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 843
Chain of thought reasoning in enhancing infectious disease diagnosis and microbiological analysis 735
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives 659
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 651
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 575
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 540
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study 532
Diagnostic Performance of ChatGPT-4o in Analyzing Oral Mucosal Lesions: A Comparative Study with Experts 520
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 334
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications 284
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 280
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 268
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 264
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group 258
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options 252
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 248
Fluoroquinolones and Biofilm: A Narrative Review 242
A case of vasculitis-like skin eruption associated with COVID-19 212
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 184
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 176
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 173
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 169
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 167
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 163
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 160
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 156
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 154
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 149
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 147
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 147
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 144
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 143
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 143
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 136
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 135
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 135
Exploring the Impact of Cabotegravir-Rilpivirine Long-Acting on Weight Gain, Body Composition, and Quality of Life in Adults Living with HIV 132
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 132
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 131
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 130
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 130
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 129
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 129
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 128
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 127
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 127
Infectious diseases screening approach among refugees: Results from a single-center study 127
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 126
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 125
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 124
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 122
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 121
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 119
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 119
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 118
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 117
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 115
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 112
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 112
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 110
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort 110
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 110
What do We Know about Cryptic Aspergillosis? 109
Living with HIV and Getting Vaccinated: A Narrative Review 107
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 106
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? 106
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 104
HBV in Italian Women’s Jail: An Underestimated Problem? 103
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 102
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 102
The current and future off-label uses of dalbavancin: a narrative review 101
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 100
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 99
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy 99
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 99
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 97
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 97
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 96
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 96
Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience 93
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges 93
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 92
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 92
Severity of lung involvement on chest x-rays in sars-coronavirus-2 infected patients as a possible tool to predict clinical progression: An observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 92
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 90
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments 89
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 89
Knowledge, Attitudes, and Practices toward Antimicrobial Resistance among Young Italian Nurses and Students: A Multicenter, Cross-Sectional Study 88
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 87
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding 86
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 81
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 80
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 80
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 80
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era 80
In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence 80
Editorial - HIV and cancer during COVID-19 pandemic: Sailing through the perfect storm 79
Enhancing AI Chatbot Responses in Health Care: The SMART Prompt Structure in Head and Neck Surgery 77
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 75
Reply letter - “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: A nationwide comparative analysis” 71
Totale 17.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022173 0 4 5 1 1 4 1 5 8 18 41 85
2022/2023646 44 74 20 96 47 97 25 80 97 15 39 12
2023/2024535 38 28 20 27 194 92 4 7 2 5 34 84
2024/20253.718 50 36 183 136 159 151 387 643 1.139 540 185 109
2025/202612.456 322 1.344 6.909 955 757 331 853 182 276 346 115 66
2026/2027684 293 391 0 0 0 0 0 0 0 0 0 0
Totale 18.363